Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?GRONLUND, B; HANSEN, H. H; HØGDALL, C et al.British journal of cancer. 2004, Vol 90, Num 2, pp 377-382, issn 0007-0920, 6 p.Article

Changes in plasma tetranectin following hip surgery with or without thrombotic complicationsHØGDALL, C. K; HØGDALL, E. V. S; JØRGENSEN, L. N et al.Thrombosis research. 1992, Vol 67, Num 4, pp 399-405, issn 0049-3848Article

Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patientsHØGDALL, C. K; HØGDALL, E. V. S; HØRDING, U et al.Scandinavian journal of clinical & laboratory investigation. 1993, Vol 53, Num 7, pp 741-746, issn 0036-5513Article

Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassayHOLTEN-ANDERSEN, M. N; SCHROHL, A.-S; BRÜNNER, N et al.The International journal of biological markers. 2003, Vol 18, Num 3, pp 170-176, issn 0393-6155, 7 p.Article

Plasma tetranectin and ovarian neoplasmsHØGDALL, C. K; HØGDALL, E. V. S; HØRDING, U et al.Gynecologic oncology (Print). 1991, Vol 43, Num 2, pp 103-107, issn 0090-8258Article

Tetranectin in amniotic fluid, maternal serum and fetal fluidsHØGDALL, E. V. S; HØGDALL, C. K; CLEMMENSEN, I et al.Scandinavian journal of clinical & laboratory investigation. 1991, Vol 51, Num 5, pp 411-415, issn 0036-5513Article